|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6,383.00 JPY | -7.22% |
|
+2.36% | -19.64% |
Company Valuation: COSMOS Pharmaceutical Corporation
Data adjusted to current consolidation scope
| Fiscal Period: May | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 603,094 | 483,107 | 525,081 | 502,890 | 700,001 | 505,899 | - | - |
| Change | - | -19.9% | 8.69% | -4.23% | 39.2% | -27.73% | - | - |
| Enterprise Value (EV) 1 | 553,560 | 450,132 | 497,354 | 477,918 | 692,920 | 485,619 | 480,298 | 477,570 |
| Change | - | -18.68% | 10.49% | -3.91% | 44.99% | -29.92% | -1.1% | -0.57% |
| P/E | 22.2x | 20.9x | 22.1x | 20.6x | 22.6x | 14.9x | 15.7x | 14.8x |
| PBR | 3.54x | 2.54x | 2.49x | 2.17x | 2.72x | 1.68x | 1.64x | 1.49x |
| PEG | - | -1.4x | 7.98x | 7.61x | 0.8x | 4.32x | 12.74x | 2.43x |
| Capitalization / Revenue | 0.83x | 0.64x | 0.63x | 0.52x | 0.69x | 0.43x | 0.43x | 0.4x |
| EV / Revenue | 0.76x | 0.6x | 0.6x | 0.5x | 0.69x | 0.44x | 0.4x | 0.38x |
| EV / EBITDA | 11.8x | 10x | 10.5x | 9.29x | 11.1x | 7.32x | 6.88x | 6.42x |
| EV / EBIT | 16.7x | 15.1x | 16.5x | 15.2x | 17.1x | 11.5x | 10.9x | 10.3x |
| EV / FCF | 65.2x | -39.1x | 93.5x | -222x | -807x | 112x | 130x | 187x |
| FCF Yield | 1.53% | -2.56% | 1.07% | -0.45% | -0.12% | -4.85% | 0.77% | 0.53% |
| Dividend per Share 2 | 35 | 40 | 50 | 60 | 70 | 82 | 84.25 | 89.11 |
| Rate of return | 0.46% | 0.66% | 0.75% | 0.95% | 0.79% | 1.36% | 1.32% | 1.4% |
| EPS 2 | 342.9 | 292.4 | 300.5 | 308.6 | 390.9 | 404.3 | 407 | 431.9 |
| Distribution rate | 10.2% | 13.7% | 16.6% | 19.4% | 17.9% | 20.3% | 20.7% | 20.6% |
| Net sales 1 | 726,424 | 755,414 | 827,697 | 964,989 | 1,011,390 | 1,099,583 | 1,189,220 | 1,271,634 |
| EBITDA 1 | 46,932 | 44,906 | 47,496 | 51,425 | 62,633 | 66,929 | 69,780 | 74,418 |
| EBIT 1 | 33,147 | 29,796 | 30,128 | 31,501 | 40,404 | 42,353 | 44,022 | 46,543 |
| Net income 1 | 27,156 | 23,155 | 23,797 | 24,454 | 30,978 | 32,046 | 32,271 | 34,240 |
| Net Debt 1 | -49,534 | -32,975 | -27,727 | -24,972 | -7,081 | -20,280 | -25,601 | -28,329 |
| Reference price 2 | 7,615.00 | 6,100.00 | 6,630.00 | 6,345.00 | 8,832.00 | 6,383.00 | 6,383.00 | 6,383.00 |
| Nbr of stocks (in thousands) | 79,198 | 79,198 | 79,198 | 79,258 | 79,257 | 79,257 | - | - |
| Announcement Date | 7/12/21 | 7/11/22 | 7/10/23 | 7/12/24 | 7/11/25 | 7/13/26 | - | - |
1JPY in Million2JPY
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 15.87x | 0.44x | 7.32x | 1.19% | 3.17B | ||
| 24.08x | 0.4x | 6.31x | 2.01% | 6.89B | ||
| 15.72x | 0.45x | 6.51x | 1.34% | 3.21B | ||
| 13.09x | 0.46x | 5.73x | 3.66% | 2.77B | ||
| 21.24x | 0.8x | 11.24x | 1.42% | 2.4B | ||
| 15.04x | 0.44x | 4.23x | 3.37% | 1.44B | ||
| 17.46x | 0.51x | 6.97x | 4.09% | 363M | ||
| Average | 17.50x | 0.50x | 6.90x | 2.44% | 2.89B | |
| Weighted average by Cap. | 18.87x | 0.48x | 6.87x | 2.06% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- 3349 Stock
- Valuation COSMOS Pharmaceutical Corporation
Select your edition
All financial news and data tailored to specific country editions
















